354 related articles for article (PubMed ID: 35196865)
1. Deletion of BACH1 Attenuates Atherosclerosis by Reducing Endothelial Inflammation.
Jia M; Li Q; Guo J; Shi W; Zhu L; Huang Y; Li Y; Wang L; Ma S; Zhuang T; Wang X; Pan Q; Wei X; Qin Y; Li X; Jin J; Zhi X; Tang J; Jing Q; Li S; Jiang L; Qu L; Osto E; Zhang J; Wang X; Yu B; Meng D
Circ Res; 2022 Apr; 130(7):1038-1055. PubMed ID: 35196865
[TBL] [Abstract][Full Text] [Related]
2. Endothelial UCP2 Is a Mechanosensitive Suppressor of Atherosclerosis.
Luo JY; Cheng CK; He L; Pu Y; Zhang Y; Lin X; Xu A; Lau CW; Tian XY; Ma RCW; Jo H; Huang Y
Circ Res; 2022 Aug; 131(5):424-441. PubMed ID: 35899624
[TBL] [Abstract][Full Text] [Related]
3. Bach1 Represses Wnt/β-Catenin Signaling and Angiogenesis.
Jiang L; Yin M; Wei X; Liu J; Wang X; Niu C; Kang X; Xu J; Zhou Z; Sun S; Wang X; Zheng X; Duan S; Yao K; Qian R; Sun N; Chen A; Wang R; Zhang J; Chen S; Meng D
Circ Res; 2015 Jul; 117(4):364-375. PubMed ID: 26123998
[TBL] [Abstract][Full Text] [Related]
4. Nogo-B mediates endothelial oxidative stress and inflammation to promote coronary atherosclerosis in pressure-overloaded mouse hearts.
Zhang Y; Li JJ; Xu R; Wang XP; Zhao XY; Fang Y; Chen YP; Ma S; Di XH; Wu W; She G; Pang ZD; Wang YD; Zhang X; Xie W; Deng XL; Du XJ; Zhang Y
Redox Biol; 2023 Dec; 68():102944. PubMed ID: 37890359
[TBL] [Abstract][Full Text] [Related]
5. Flow-dependent YAP/TAZ activities regulate endothelial phenotypes and atherosclerosis.
Wang KC; Yeh YT; Nguyen P; Limqueco E; Lopez J; Thorossian S; Guan KL; Li YJ; Chien S
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11525-11530. PubMed ID: 27671657
[TBL] [Abstract][Full Text] [Related]
6. RGC-32 (Response Gene to Complement 32) Deficiency Protects Endothelial Cells From Inflammation and Attenuates Atherosclerosis.
Cui XB; Luan JN; Dong K; Chen S; Wang Y; Watford WT; Chen SY
Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):e36-e47. PubMed ID: 29449334
[TBL] [Abstract][Full Text] [Related]
7. c-Abl regulates YAPY357 phosphorylation to activate endothelial atherogenic responses to disturbed flow.
Li B; He J; Lv H; Liu Y; Lv X; Zhang C; Zhu Y; Ai D
J Clin Invest; 2019 Mar; 129(3):1167-1179. PubMed ID: 30629551
[TBL] [Abstract][Full Text] [Related]
8. Role of Hic-5 in the formation of microvilli-like structures and the monocyte-endothelial interaction that accelerates atherosclerosis.
Arita-Okubo S; Kim-Kaneyama JR; Lei XF; Fu WG; Ohnishi K; Takeya M; Miyauchi A; Honda H; Itabe H; Miyazaki T; Miyazaki A
Cardiovasc Res; 2015 Mar; 105(3):361-71. PubMed ID: 25587044
[TBL] [Abstract][Full Text] [Related]
9. Endothelial Foxp1 Suppresses Atherosclerosis via Modulation of Nlrp3 Inflammasome Activation.
Zhuang T; Liu J; Chen X; Zhang L; Pi J; Sun H; Li L; Bauer R; Wang H; Yu Z; Zhang Q; Tomlinson B; Chan P; Zheng X; Morrisey E; Liu Z; Reilly M; Zhang Y
Circ Res; 2019 Aug; 125(6):590-605. PubMed ID: 31318658
[TBL] [Abstract][Full Text] [Related]
10. UHRF1 inhibition mitigates vascular endothelial cell injury and ameliorates atherosclerosis in mice via regulating the SMAD7/YAP1 axis.
Li W; Bai P; Li W
Mol Immunol; 2024 Jun; 170():119-130. PubMed ID: 38657333
[TBL] [Abstract][Full Text] [Related]
11. Novel interaction of antioxidant-1 with TRAF4: role in inflammatory responses in endothelial cells.
Das A; Sudhahar V; Ushio-Fukai M; Fukai T
Am J Physiol Cell Physiol; 2019 Dec; 317(6):C1161-C1171. PubMed ID: 31553645
[TBL] [Abstract][Full Text] [Related]
12. Piezo1 mediates endothelial atherogenic inflammatory responses via regulation of YAP/TAZ activation.
Yang Y; Wang D; Zhang C; Yang W; Li C; Gao Z; Pei K; Li Y
Hum Cell; 2022 Jan; 35(1):51-62. PubMed ID: 34606042
[TBL] [Abstract][Full Text] [Related]
13. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
[TBL] [Abstract][Full Text] [Related]
14. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243
[TBL] [Abstract][Full Text] [Related]
15. Atheroprotective laminar flow inhibits Hippo pathway effector YAP in endothelial cells.
Xu S; Koroleva M; Yin M; Jin ZG
Transl Res; 2016 Oct; 176():18-28.e2. PubMed ID: 27295628
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of long noncoding RNA HIF1A-AS2 confers protection against atherosclerosis
Li P; Xing J; Zhang J; Jiang J; Liu X; Zhao D; Zhang Y
J Adv Res; 2020 Nov; 26():123-135. PubMed ID: 33133688
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting Endoplasmic Reticulum (ER) Stress Induced by Disturbed Flow.
Chung J; Kim KH; Lee SC; An SH; Kwon K
Mol Cells; 2015 Oct; 38(10):851-8. PubMed ID: 26442866
[TBL] [Abstract][Full Text] [Related]
18. Vascular Semaphorin 7A Upregulation by Disturbed Flow Promotes Atherosclerosis Through Endothelial β1 Integrin.
Hu S; Liu Y; You T; Heath J; Xu L; Zheng X; Wang A; Wang Y; Li F; Yang F; Cao Y; Zhang H; van Gils JM; van Zonneveld AJ; Jo H; Wu Q; Zhang Y; Tang C; Zhu L
Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):335-343. PubMed ID: 29269512
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.
Singh KK; Shukla PC; Quan A; Al-Omran M; Lovren F; Pan Y; Brezden-Masley C; Ingram AJ; Stanford WL; Teoh H; Verma S
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):949-960.e4. PubMed ID: 23415688
[TBL] [Abstract][Full Text] [Related]
20. Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow.
Liu D; Lv H; Liu Q; Sun Y; Hou S; Zhang L; Yang M; Han B; Wang G; Wang X; Du W; Nie H; Zhang R; Huang X; Hou J; Yu B
J Transl Med; 2019 Nov; 17(1):378. PubMed ID: 31730006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
